841 related articles for article (PubMed ID: 31221620)
21. Experiences, expectations and preferences regarding MRI and mammography as breast cancer screening tools in women at familial risk.
Geuzinge HA; Heijnsdijk EAM; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
Breast; 2021 Apr; 56():1-6. PubMed ID: 33515770
[TBL] [Abstract][Full Text] [Related]
22. Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.
Passaperuma K; Warner E; Causer PA; Hill KA; Messner S; Wong JW; Jong RA; Wright FC; Yaffe MJ; Ramsay EA; Balasingham S; Verity L; Eisen A; Curpen B; Shumak R; Plewes DB; Narod SA
Br J Cancer; 2012 Jun; 107(1):24-30. PubMed ID: 22588560
[TBL] [Abstract][Full Text] [Related]
23. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
[TBL] [Abstract][Full Text] [Related]
24. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.
FH01 collaborative teams
Lancet Oncol; 2010 Dec; 11(12):1127-34. PubMed ID: 21093374
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.
Le-Petross HT; Whitman GJ; Atchley DP; Yuan Y; Gutierrez-Barrera A; Hortobagyi GN; Litton JK; Arun BK
Cancer; 2011 Sep; 117(17):3900-7. PubMed ID: 21365619
[TBL] [Abstract][Full Text] [Related]
26. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
[TBL] [Abstract][Full Text] [Related]
27. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
[TBL] [Abstract][Full Text] [Related]
28. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
Mango VL; Goel A; Mema E; Kwak E; Ha R
J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
[TBL] [Abstract][Full Text] [Related]
29. MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC).
Kriege M; Brekelmans CT; Boetes C; Rutgers EJ; Oosterwijk JC; Tollenaar RA; Manoliu RA; Holland R; de Koning HJ; Klijn JG
Fam Cancer; 2001; 1(3-4):163-8. PubMed ID: 14574173
[TBL] [Abstract][Full Text] [Related]
30. Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.
Krammer J; Pinker-Domenig K; Robson ME; Gönen M; Bernard-Davila B; Morris EA; Mangino DA; Jochelson MS
Breast Cancer Res Treat; 2017 Jun; 163(3):565-571. PubMed ID: 28343309
[TBL] [Abstract][Full Text] [Related]
31. Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis.
Phi XA; Greuter MJW; Obdeijn IM; Oosterwijk JC; Feenstra TL; Houssami N; de Bock GH
Breast; 2019 Jun; 45():82-88. PubMed ID: 30904701
[TBL] [Abstract][Full Text] [Related]
32. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
[TBL] [Abstract][Full Text] [Related]
34. [Choices for women at risk of hereditary breast cancer].
Saadatmand S; Obdeijn IM; Koppert LB; Tilanus-Linthorst M
Ned Tijdschr Geneeskd; 2013; 157(43):A6625. PubMed ID: 24152366
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
[TBL] [Abstract][Full Text] [Related]
36. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
37. First experiences in screening women at high risk for breast cancer with MR imaging.
Tilanus-Linthorst MM; Obdeijn IM; Bartels KC; de Koning HJ; Oudkerk M
Breast Cancer Res Treat; 2000 Sep; 63(1):53-60. PubMed ID: 11079159
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Besnard PE; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Peterse H; Tilanus-Linthorst MM; Muller SH; Meijer S; Oosterwijk JC; Beex LV; Tollenaar RA; de Koning HJ; Rutgers EJ; Klijn JG;
N Engl J Med; 2004 Jul; 351(5):427-37. PubMed ID: 15282350
[TBL] [Abstract][Full Text] [Related]
39. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer.
Warner E; Plewes DB; Shumak RS; Catzavelos GC; Di Prospero LS; Yaffe MJ; Goel V; Ramsay E; Chart PL; Cole DE; Taylor GA; Cutrara M; Samuels TH; Murphy JP; Murphy JM; Narod SA
J Clin Oncol; 2001 Aug; 19(15):3524-31. PubMed ID: 11481359
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
